These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22479349)

  • 1. Estimating individual exposure to malaria using local prevalence of malaria infection in the field.
    Olotu A; Fegan G; Wambua J; Nyangweso G; Ogada E; Drakeley C; Marsh K; Bejon P
    PLoS One; 2012; 7(3):e32929. PubMed ID: 22479349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya.
    Ibison F; Olotu A; Muema DM; Mwacharo J; Ohuma E; Kimani D; Marsh K; Bejon P; Ndungu FM
    PLoS One; 2012; 7(12):e52939. PubMed ID: 23300828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria.
    Murungi LM; Kamuyu G; Lowe B; Bejon P; Theisen M; Kinyanjui SM; Marsh K; Osier FH
    Vaccine; 2013 Aug; 31(37):3936-42. PubMed ID: 23800539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana.
    Dodoo D; Atuguba F; Bosomprah S; Ansah NA; Ansah P; Lamptey H; Egyir B; Oduro AR; Gyan B; Hodgson A; Koram KA
    Malar J; 2011 May; 10():108. PubMed ID: 21529376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to polymorphic invasion-inhibitory and non-Inhibitory epitopes of Plasmodium falciparum apical membrane antigen 1 in human malaria.
    Mugyenyi CK; Elliott SR; McCallum FJ; Anders RF; Marsh K; Beeson JG
    PLoS One; 2013; 8(7):e68304. PubMed ID: 23861883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between maternally derived antibodies and heterogeneity in exposure combined to determine time-to-first Plasmodium falciparum infection in Kenyan infants.
    Reynaldi A; Dent AE; Schlub TE; Ogolla S; Rochford R; Davenport MP
    Malar J; 2019 Jan; 18(1):19. PubMed ID: 30670032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leukocyte antigen class II alleles influence levels of antibodies to the Plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1.
    Johnson AH; Leke RG; Mendell NR; Shon D; Suh YJ; Bomba-Nkolo D; Tchinda V; Kouontchou S; Thuita LW; van der Wel AM; Thomas A; Stowers A; Saul A; Zhou A; Taylor DW; Quakyi IA
    Infect Immun; 2004 May; 72(5):2762-71. PubMed ID: 15102786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.
    Adamou R; Dechavanne C; Sadissou I; d'Almeida T; Bouraima A; Sonon P; Amoussa R; Cottrell G; Le Port A; Theisen M; Remarque EJ; Longacre S; Moutairou K; Massougbodji A; Luty AJF; Nuel G; Migot-Nabias F; Sanni A; Garcia A; Milet J; Courtin D
    Malar J; 2019 Jun; 18(1):194. PubMed ID: 31185998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sero-catalytic and Antibody Acquisition Models to Estimate Differing Malaria Transmission Intensities in Western Kenya.
    Weber GE; White MT; Babakhanyan A; Sumba PO; Vulule J; Ely D; John C; Angov E; Lanar D; Dutta S; Narum DL; Horii T; Cowman A; Beeson J; Smith J; Kazura JW; Dent AE
    Sci Rep; 2017 Dec; 7(1):16821. PubMed ID: 29203846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya.
    Agak GW; Bejon P; Fegan G; Gicheru N; Villard V; Kajava AV; Marsh K; Corradin G
    Vaccine; 2008 Apr; 26(16):1963-71. PubMed ID: 18342997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malaria transmission and individual variability of the naturally acquired IgG antibody against the Plasmodium vivax blood-stage antigen in an endemic area in Brazil.
    Costa EMF; Amador ECC; Silva ES; Alvarenga CO; Pereira PE; Póvoa MM; Cunha MG
    Acta Trop; 2020 Sep; 209():105537. PubMed ID: 32454033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study.
    Dobaño C; Ubillos I; Jairoce C; Gyan B; Vidal M; Jiménez A; Santano R; Dosoo D; Nhabomba AJ; Ayestaran A; Aguilar R; Williams NA; Díez-Padrisa N; Lanar D; Chauhan V; Chitnis C; Dutta S; Gaur D; Angov E; Asante KP; Owusu-Agyei S; Valim C; Gamain B; Coppel RL; Cavanagh D; Beeson JG; Campo JJ; Moncunill G
    BMC Med; 2019 Aug; 17(1):157. PubMed ID: 31409398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses and avidity of naturally acquired anti-Plasmodium vivax Duffy binding protein (PvDBP) antibodies in individuals from an area with unstable malaria transmission.
    Zakeri S; Babaeekhou L; Mehrizi AA; Abbasi M; Djadid ND
    Am J Trop Med Hyg; 2011 Jun; 84(6):944-50. PubMed ID: 21633032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.
    Osier FH; Fegan G; Polley SD; Murungi L; Verra F; Tetteh KK; Lowe B; Mwangi T; Bull PC; Thomas AW; Cavanagh DR; McBride JS; Lanar DE; Mackinnon MJ; Conway DJ; Marsh K
    Infect Immun; 2008 May; 76(5):2240-8. PubMed ID: 18316390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological markers for monitoring historical changes in malaria transmission intensity in a highly endemic region of Western Kenya, 1994-2009.
    Wong J; Hamel MJ; Drakeley CJ; Kariuki S; Shi YP; Lal AA; Nahlen BL; Bloland PB; Lindblade KA; Were V; Otieno K; Otieno P; Odero C; Slutsker L; Vulule JM; Gimnig JE
    Malar J; 2014 Nov; 13():451. PubMed ID: 25416454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of IgG3 anti ICB2-5 in Plasmodium vivax-infected individuals who did not develop symptoms.
    Versiani FG; Almeida ME; Melo GC; Versiani FO; Orlandi PP; Mariúba LA; Soares LA; Souza LP; da Silva Balieiro AA; Monteiro WM; Costa FT; del Portillo HA; Lacerda MV; Nogueira PA
    Malar J; 2013 Aug; 12():294. PubMed ID: 23977965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serologically defined variations in malaria endemicity in Pará state, Brazil.
    Cunha MG; Silva ES; Sepúlveda N; Costa SP; Saboia TC; Guerreiro JF; Póvoa MM; Corran PH; Riley E; Drakeley CJ
    PLoS One; 2014; 9(11):e113357. PubMed ID: 25419900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malaria hotspots defined by clinical malaria, asymptomatic carriage, PCR and vector numbers in a low transmission area on the Kenyan Coast.
    Kangoye DT; Noor A; Midega J; Mwongeli J; Mkabili D; Mogeni P; Kerubo C; Akoo P; Mwangangi J; Drakeley C; Marsh K; Bejon P; Njuguna P
    Malar J; 2016 Apr; 15():213. PubMed ID: 27075879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya.
    Dent AE; Nakajima R; Liang L; Baum E; Moormann AM; Sumba PO; Vulule J; Babineau D; Randall A; Davies DH; Felgner PL; Kazura JW
    J Infect Dis; 2015 Nov; 212(9):1429-38. PubMed ID: 25883384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of merozoite surface protein 1 and apical membrane antigen 1 vaccine efficacies against Plasmodium chabaudi malaria based on prechallenge antibody responses.
    Lynch MM; Cernetich-Ott A; Weidanz WP; Burns JM
    Clin Vaccine Immunol; 2009 Mar; 16(3):293-302. PubMed ID: 19116303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.